Published by If you or a loved one was implanted with a BioFlo® or other AngioFlow/TIVAD port and experienced complications such as infection, catheter fracture, migration, or required revision surgery, you may have a claim.
Contact our experienced medical-device litigation team today for a free, no-obligation evaluation tailored to your situation.
Table Of Contents
What’s the Problem?
The BioFlo® venous access port is an implantable catheter system manufactured by AngioDynamics and marketed for long-term vascular access, often used by chemotherapy patients or those requiring repeated IV infusion.
Several lawsuits allege that the device contains design and manufacturing defects—including excessive barium sulfate in the catheter tubing—which can lead to cracking, migration, leakage or infection. [1]
Similar ports have been linked to hundreds of product-liability claims and a consolidated federal multidistrict litigation (MDL-3125) established October 2024. [2]
Although the BioFlo model is a part of this umbrella litigation, no publicly disclosed settlement or resolution has been finalized at time of writing.
Latest Updates
- October 3, 2024 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated lawsuits involving AngioDynamics port-catheter products—including BioFlo ports—into MDL 3125 in the Southern District of California. [3]
- September 26, 2025 – A civil complaint filed in Texas alleges that a BioFlo port fractured, caused infection and required removal in 2021; the manufacturer had allegedly received adverse event reports yet failed to warn patients or doctors. [1]
- November 2025 – Attorneys report an increase in client intake specifically related to BioFlo-brand ports, with internal data showing surgeons identifying cracks, bleeding and thrombosis in patients implanted between 2013–2020. Legal sources indicate discovery disclosures will commence in early 2026. [4]
Product & Usage Overview
Implantable venous access systems like the BioFlo port consist of a subcutaneous reservoir (port) connected to a tunneled or implanted catheter that terminates in a central vein. These devices are used when long-term, repeated IV access is required. Although licensed under general venous access indications, BioFlo and similar ports are often used for chemotherapy infusion, transfusions or parenteral nutrition.
When functioning properly, the port system allows medications or fluids to be administered with minimal venous access trauma. However, plaintiffs in the litigation claim that BioFlo devices were designed with materials that degrade prematurely—particularly catheter tubing incorporating too much barium sulfate filler—which may cause fractures or leaks, leading to severe injury and systemic infection. [5]
Injuries & Side Effects
Adverse events reported in BioFlo port cases include the following:
– Device fracture or catheter crack, often leading to leakage of medication into tissue rather than vein, causing pain, swelling or necrosis.
– Migration of catheter fragments to the lung, heart or elsewhere, causing embolism or organ trauma.
– Deep venous thrombosis (DVT), pulmonary embolism, vascular perforation and bleeding due to dysfunction of the port system.
– Infection or sepsis resulting from device failure, often requiring explantation and systemic antibiotics. For example one complaint notes infection and revision surgery in a patient implanted in 2014 who required removal in 2021. [1]
– Additional surgeries, extended hospitalization, lost productivity and long-term impairment.
These complications form the basis of potential claims against AngioDynamics for the BioFlo port.
Do You Qualify for a BioFlo Port Lawsuit?
You may be eligible if you:
– Had a BioFlo® or other AngioDynamics port-catheter implanted (including models SmartPort, Vortex, Xcela)
– Experienced one or more complications including device failure, catheter fracture, migration, infection, thrombosis or necessary revision surgery
– Have medical or surgical records identifying the device model and surgeon notes addressing complications
– Are within the statute of limitations for your state (typically 1-3 years from knowledge of injury or revision)
Evidence Required
To pursue a claim you should gather:
– Surgical implant records showing device model and date
– Medical records of complications, interventions, revision surgery, treatment of infection or DVT
– Imaging or pathology verifying device failure (fracture, migration, leakage)
– Device explant specimen or operative report documenting what was removed
– Proof of implantation and complications to support causation and liability
Damages You Can Recover
Possible compensation may include:
– Medical costs: surgical removal, revision procedure, hospitalization, rehabilitation
– Lost wages or diminished earning capacity due to recovery or ongoing medical condition
– Pain and suffering, emotional distress, disfigurement or reduced quality of life
– Future medical monitoring or procedures if device failure triggers long-term harm
– In jurisdictions allowing punitive damages, if manufacturer misconduct is proven
Legal Theories & Liability Grounds
Claims against AngioDynamics for the BioFlo port may include:
– Design defect: The BioFlo port catheter allegedly incorporates excessive barium sulfate causing brittleness and fracture risk. [4]
– Manufacturing defect: Individual units may deviate from design specs, fail prematurely and cause harm.
– Failure to warn: Law suits allege that AngioDynamics knew of significant adverse reports but failed to warn physicians or patients appropriately. [1]
– Strict liability: Device is unreasonably dangerous when used as intended, manufacturer liable for failures.
– Breach of warranty: The port was sold as safe for long-term use, yet failed under normal conditions.
This suite of liability theories underpins the broader port-catheter mass-tort litigation and supports individual BioFlo claims.
Statute of Limitations & Timing
Each state sets its own statute of limitations for medical-device claims; many allow one to three years from the date of discovery of injury or revision surgery. Because device failure may not become apparent until years after implantation, early consultation helps determine deadlines and preserve your rights.
Frequently Asked Questions
- Is there a class action lawsuit for BioFlo ports? – No verified class action strictly for BioFlo ports has been publicly reported yet, but the BioFlo model is part of a larger MDL covering AngioDynamics port catheter claims. [3]
- Can I claim if my port was removed but no fracture was confirmed? – Potentially yes, especially if you documented revision surgery due to device failure or complications linked to the model.
- Do I need proof the device was the cause? – Evidence of the device model, surgeon notes, medical records and causation support your claim; your attorney will assist with expert analysis when needed.
References
- https://www.aboutlawsuits.com/angiodynamics-port-catheter-lawsuit/angiodynamics-bioflo-port-catheters-defectively-designed/
- https://www.doyleapc.com/medical-devices/san-diego-court-to-oversee-angiodynamics-port-catheter-lawsuits/
- https://www.torhoermanlaw.com/angiodynamics-port-catheter-lawsuit/
- https://www.peircelaw.com/defective-medical-devices/angiodynamics-port-catheter/
- https://www.youhavealawyer.com/port-catheter-lawsuit/